Virtu Financial’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Virtu Financial’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,933	Closed	-$88K	–	2436
2022 Q4	$88K	Buy	+13,933	New	+$77.1K	0.01%	991
2018 Q2	–	Sell	-2,911	Closed	-$179K	–	2643
2018 Q1	$179K	Sell	2,911 -286	-9%	-$15.1K	0.01%	1405
2017 Q4	$172K	Buy	+3,197	New	+$190K	0.01%	1749

Virtu Financial's FSTX Position: Q1 2023 in Review

Virtu Financial sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 13,933 shares — an estimated $88K sold.

Virtu Financial first reported a position in FSTX in Q4 2017 and held it in 3 quarters. The position peaked at $179K in Q1 2018. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Virtu Financial reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Virtu Financial sold 13,933 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $88K.
Virtu Financial first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
Virtu Financial's F-star Therapeutics, Inc. Common Stock position peaked at $179K in Q1 2018.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.